Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Resmed Inc (NY: RMD )

163.49 -0.51 (-0.31%)
Official Closing Price Updated: 4:10 PM EST, Dec 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 849,362
Open 163.84
Bid (Size) 153.74 (1)
Ask (Size) 163.22 (1)
Prev. Close 164.00
Today's Range 162.05 - 164.74
52wk Range 132.24 - 243.52
Shares Outstanding 146,234,244
Dividend Yield 1.17%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
From ResMed Inc.
Via GlobeNewswire
Why NYSE:RMD qualifies as a good dividend investing stock.
Is RESMED INC (NYSE:RMD) a Good Fit for Dividend Investing? 
Via Chartmill

Performance

YTD
-21.82%
-21.82%
1 Month
+6.25%
+6.25%
3 Month
+6.63%
+6.63%
6 Month
-25.34%
-25.34%
1 Year
-24.91%
-24.91%

More News

Read More
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion
Via Benzinga
Why the dividend investor may take a look at NYSE:RMD.
Via Chartmill
Is NYSE:RMD a Good Fit for Dividend Investing?
Via Chartmill
Expert Ratings for ResMed
Via Benzinga
ResMed Adopts New Operating Model to Accelerate Long-term Growth
From ResMed Inc.
Via GlobeNewswire
2 Monster Stocks to Buy Without Any Hesitation
Via The Motley Fool
How Sleep Device Player ResMed Is Gaining Philips' Market Share In Flow Generator Market - Analysts Weigh In
Via Benzinga
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Via Investor's Business Daily
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
From ResMed Inc.
Via GlobeNewswire
Earnings Scheduled For October 26, 2023
Via Benzinga
3 Stocks to Buy From the ‘Buy the Dip’ ETF
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2023
Via Benzinga
Exxon Mobil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
From ResMed Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
3 Top Growth Stock Picks Trading at a Massive Bargain
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Sleep Device Player ResMed's Potential Obstacles: Analyst Weighs Obesity Drugs & Philips' Re-Entry
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
Via Benzinga
ResMed Announces Participation in Upcoming Conferences
From ResMed Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.